JAMIE BRISENDINE: Open Payments
NPI 1225086218 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,339 in 79 payments from 13 companies in 2025. Trend: 2023 $1,100 · 2024 $1,278 · 2025 $1,339
Food & beverage: $1,339
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 53 | $771 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $151 |
| PFIZER INC. | 11 | $145 |
| Alexion Pharmaceuticals, Inc. | 3 | $79 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| Lundbeck LLC | 1 | $23 |
| Impel Pharmaceuticals LLC | 1 | $22 |
| Tetraphase Pharmaceuticals, Inc. | 1 | $22 |
Products named: QULIPTA, UBRELVY, LifeVest, NURTEC ODT, BOTOX, ULTOMIRIS, ZAVZPRET, VRAYLAR.
Industry payments across PA — which companies pay providers there.
